FEMARA

This brand name is authorized in Austria, Australia, Brazil, Canada, Cyprus, Germany, Ecuador, Estonia, Spain, France, Hong Kong, Croatia, Ireland, Israel, Italy, Japan, Lithuania, Malta, Mexico, Nigeria, Netherlands, New Zealand, Singapore, Tunisia, Turkey, United Kingdom, United States

Active ingredients

The drug FEMARA contains one active pharmaceutical ingredient (API):

1 Letrozole UNII 7LKK855W8I - LETROZOLE

Letrozole is a non-steroidal aromatase inhibitor. It inhibits the aromatase enzyme by competitively binding to the haem of the aromatase cytochrome P450, resulting in a reduction of oestrogen biosynthesis in all tissues where present. Read about Letrozole

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
FEMARA Film-coated tablet	Health Products Regulatory Authority (IE)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
L02BG04	Letrozole	L Antineoplastic and immunomodulating agents → L02 Endocrine therapy → L02B Hormone antagonists and related agents → L02BG Aromatase inhibitors
Discover more medicines within L02BG04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 8245Y
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 526506301112216
Country: CA	Health Products and Food Branch	Identifier(s): 02231384
Country: DE	Bundesinstitut für Arzneimittel und Medizinprodukte	Identifier(s): 00980760, 01287819, 01605248, 02129229, 05388109, 07314606, 07614923, 07614946, 09233763, 09711872, 09923947
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 21.644-1-11-04
Country: EE	Ravimiamet	Identifier(s): 1034334, 1642340, 1642351, 1642362, 1642373, 1730775, 1730786, 1730797, 1730809, 1730810
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 303848-10-2001, 61628
Country: FR	Base de données publique des médicaments	Identifier(s): 64492112, 64721664, 64722435, 67359220, 68432511
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 240327, 368018, 381335
Country: HK	Department of Health Drug Office	Identifier(s): 42537
Country: HR	Agencija za lijekove i medicinske proizvode	Identifier(s): HR-H-020668711
Country: IE	Health Products Regulatory Authority	Identifier(s): 24571, 24572, 24701
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 3637
Country: IT	Agenzia del Farmaco	Identifier(s): 033242013, 044537025, 047270020
Country: JP	医薬品医療機器総合機構	Identifier(s): 4291015F1026
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1003012, 1073026, 1073027, 1073028, 1073029
Country: MT	Medicines Authority	Identifier(s): MA1249/02301
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 521M98
Country: NG	Registered Drug Product Database	Identifier(s): A4-3436
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 47724
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 6846
Country: SG	Health Sciences Authority	Identifier(s): 09915P
Country: TN	Direction de la Pharmacie et du Médicament	Identifier(s): 10283061H
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699504090253
Country: US	FDA, National Drug Code	Identifier(s): 0078-0249